Clinical Trial: Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer

U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07811895) titled 'Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer' on Aug. 27.

Brief Summary: To evaluate the efficacy and safety of Dual GIP/GLP-1 receptor agonist pretreatment on reproductive outcomes in obese women before frozen embryo transfer.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Tirzepatide Frozen Embryo Transfer Obesity

Intervention: DRUG: Dual GIP/GLP-1 receptor agonist

16 weeks treatment

Recruitment Status: NOT_YET_RECRUITING

Sponsor: RenJi Hospital

Information provided by (Responsible Party): Yun Sun, RenJi Hospital

Disclaimer: Curated by HT Syndication....